Table 3.
Target (11–12 years) | Catch-Up (13–21 years) | ||||||
---|---|---|---|---|---|---|---|
2nd Dose HPV Vaccine |
2nd Dose HPV Vaccine |
||||||
Yes (n=261) |
No (n=232) |
aOR (95% CI) |
Yes (n=603) |
No (n=667) |
aOR (95% CI) |
||
Mean Baseline Age (SD) | 11.43 (0.5) |
11.46 (0.5) |
0.86 (0.65 – 1.13) |
15.55 (2.1) |
15.97 (2.2) |
0.95 (0.88 – 1.02) |
|
Race/Ethnicity n | |||||||
White | 104 | 43 | 1.0 (Reference) |
257 | 147 | 1.0 (Reference) |
|
Black | 132 | 160 | 0.63 (0.40 – 1.00) |
283 | 458 | 0.65 (0.46 – 0.92) |
|
Hispanic | 8 | 10 | 0.39 (0.17 – 0.89) |
21 | 23 | 0.72 (0.33 – 1.54) |
|
Asian | 6 | 4 | 0.50 (0.17 – 1.46) |
10 | 7 | 1.11 (0.52 – 2.40) |
|
Other | 11 | 15 | 0.26 (0.09 – 0.81) |
32 | 32 | 0.71 (0.37 – 1.37) |
|
Insurance Type n | |||||||
Private | 100 | 61 | 1.0 (Reference) |
266 | 230 | 1.0 (Reference) |
|
Public | 104 | 142 | 0.77 (0.43 – 1.39) |
195 | 347 | 0.73 (0.56 – 0.96) |
|
Military | 57 | 29 | 1.03 (0.60 – 1.79) |
138 | 86 | 0.78 (0.52 – 1.16) |
|
Number of Clinic Visits n | |||||||
1–3 Visits | 136 | 194 | 1.0 (Reference) |
326 | 596 | 1.0 (Reference) |
|
>3 Visits | 125 | 38 | 4.01 (3.22 – 4.99) |
277 | 71 | 5.82 (4.13 – 8.20) |
|
JHCP Clinic Location n | |||||||
Suburban | 149 | 89 | 1.0 (Reference) |
374 | 273 | 1.0 (Reference) |
|
Urban | 112 | 143 | 1.08 (0.35 – 3.34) |
229 | 394 | 0.77 (0.46 – 1.31) |
|
JHCP Specialty n | |||||||
Family Practice | 64 | 37 | 1.0 (Reference) |
205 | 149 | 1.0 (Reference) |
|
IM/Peds | 19 | 13 | 0.63 (0.34 – 1.19) |
32 | 44 | 0.52 (0.28 – 0.97) |
|
Internal Med | 0 | 3 | 1.00 (1.00 – 1.00) |
17 | 28 | 0.65 (0.31 – 1.40) |
|
Pediatrics | 178 | 179 | 0.57 (0.30 – 1.06) |
349 | 446 | 1.07 (0.74 – 1.54) |
All models mutually adjusted for all variables listed in the table. Results for the permissive age group are not shown due to limited statistical power
Abbreviations: aOR – Adjusted Odds Ratio; CI, Confidence Interval; Asian/Pacific Is., Asian/Pacific Islander; IM/Peds, Internal Medicine/Pediatrics; Internal Med, Internal Medicine